Dindic, Bb Girl .
HRN: 26-57-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/15/2025
03/21/2025
IVT
350mg
Q6
PCAP-D
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes